No human trial has established reversal of biological ageing, frailty, age-related disease or mortality
Together, increased calcium levels and PKC activation may support the release of growth hormone from storage vesicles within the pituitary cells
The most trustworthy longevity care tends to feel steady and collaborative
Most common adverse events at all doses: Nausea (15-30%, dose-related) Vomiting (5-15%) Decreased appetite (~20%) Constipation (5-12%) Cagrilintide-specific notes: A 2025 Bayesian network meta-analysis of incretin-based therapies reported cagrilintide had one of the lowest GI odds ratios across the studied compound class
Its well-characterized biological activity has generated significant interest across musculoskeletal, gastrointestinal, vascular, and connective tissue research
Since your own plasma is used in injections, the risk of side effects is exceptionally low